BRAF mutations were observed in 75% (3/4) of cases of SSL-like dysplasia in colitis-affected segments and in all SSLs in colitis-unaffected segments, whereas KRAS mutations were observed in all cases of TSA-like dysplasia in colitis-affected segments and in all TSAs in colitis-unaffected segments. Here, KRAS is linked to dysplasia.